HF
CELZ icon

HRT Financial’s Creative Medical Technology CELZ Stock Holding History

HRT Financial’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,053
Closed -$28K – 2713
2025
Q1 		$28K Buy
+13,053
New +$45.5K ﹤0.01% 2275
2024
Q2 		– Sell
-13,194
Closed -$68K – 2311
2024
Q1 		$68K Buy
+13,194
New +$61.4K ﹤0.01% 1901

Other funds holding CELZ

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's CELZ Position: Q2 2025 in Review

HRT Financial sold out of Creative Medical Technology (CELZ) in Q2 2025, closing a stake of 13,053 shares — an estimated $28K sold.

HRT Financial first reported a position in CELZ in Q1 2024 and held it in 2 quarters. The position peaked at $68K in Q1 2024. 12 funds tracked by Wall St. Rank hold CELZ as of Q2 2025.

  • HRT Financial reported no remaining Creative Medical Technology position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 13,053 Creative Medical Technology shares in Q2 2025, an estimated $28K.
  • HRT Financial first reported a position in Creative Medical Technology in Q1 2024 and held it in 2 quarters.
  • HRT Financial's Creative Medical Technology position peaked at $68K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.